Literature DB >> 11318980

Enhanced expression of endothelin receptor subtypes in cirrhotic rat liver.

H Yokomori1, M Oda, M Ogi, Y Kamegaya, N Tsukada, M Nakamura, H Ishii.   

Abstract

BACKGROUND/AIMS: A number of vasoactive substances have been implicated as potential mediators of intrahepatic portal hypertension. Endothelin (ET)-1 has been suggested to be involved in the regulation of hepatic microcirculation and development of portal hypertension. The aim of this study was to clarify the localization of two subtypes of ET receptors, ET A (ETAR) and B receptors (ETBR), in normal rat liver, and how the receptor expressions are altered in CCl4-induced cirrhotic rat liver.
METHODS: Liver specimens were examined immunohistochemically after reacting with anti-ETAR and anti-ETBR rabbit polyclonal antibodies. Immunogold staining was also performed using the same antibodies, and examined under light and electron microscopy.
RESULTS: In normal rat liver, immunohistochemistry revealed expression of ETAR and ETBR on the hepatic sinusoidal lining cells. By immunogold electron microscopy, electron-dense gold particles indicating the presence of ETARs were localized mainly on hepatic stellate cells (HSCs) and to a lesser extent on sinusoidal endothelial cells (SECs), while ETBRs were expressed equally intensely on HSCs and SECs. In cirrhotic animals, both ETAR and ETBR increased significantly on HSCs, while there were no significant increases in either receptor on SECs.
CONCLUSIONS: In the normal state, HSCs possess both ETARs and ETBRs, while SECs mainly possess ETBRs. In cirrhosis, endothelins may exert more intense effects on HSCs via the enhanced ETARs and ETBRs, causing an increase in hepatic sinusoidal microvascular tone.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11318980     DOI: 10.1034/j.1600-0676.2001.021002114.x

Source DB:  PubMed          Journal:  Liver        ISSN: 0106-9543


  20 in total

Review 1.  Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension.

Authors:  H Reynaert; M G Thompson; T Thomas; A Geerts
Journal:  Gut       Date:  2002-04       Impact factor: 23.059

Review 2.  Role of endothelin in systemic and portal resistance in cirrhosis.

Authors:  P W Angus
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

3.  A hepatic stellate cell gene expression signature associated with outcomes in hepatitis C cirrhosis and hepatocellular carcinoma after curative resection.

Authors:  David Y Zhang; Nicolas Goossens; Jinsheng Guo; Ming-Chao Tsai; Hsin-I Chou; Civan Altunkaynak; Angelo Sangiovanni; Massimo Iavarone; Massomo Colombo; Masahiro Kobayashi; Hiromitsu Kumada; Augusto Villanueva; Josep M Llovet; Yujin Hoshida; Scott L Friedman
Journal:  Gut       Date:  2015-06-04       Impact factor: 23.059

Review 4.  Pathophysiology and Management of Variceal Bleeding.

Authors:  Saleh A Alqahtani; Sunguk Jang
Journal:  Drugs       Date:  2021-03-12       Impact factor: 9.546

5.  Increased immunoreactivities against endothelin-converting enzyme-1 and monocyte chemotactic protein-1 in hepatic stellate cells of rat fibrous liver induced by thioacetamide.

Authors:  Takahisa Nagata; Hideaki Kudo; Tomoko Nishino; Yoshiaki Doi; Hideaki Itoh; Sunao Fujimoto
Journal:  Med Mol Morphol       Date:  2005-09       Impact factor: 2.309

6.  Current status of novel antifibrotic therapies in patients with chronic liver disease.

Authors:  Michal Cohen-Naftaly; Scott L Friedman
Journal:  Therap Adv Gastroenterol       Date:  2011-11       Impact factor: 4.409

7.  An endothelin A receptor antagonist induces dilatation of sinusoidal endothelial fenestrae: implications for endothelin-1 in hepatic microcirculation.

Authors:  Norihito Watanabe; Shinji Takashimizu; Yasuhiro Nishizaki; Seiichiro Kojima; Tatehiro Kagawa; Shohei Matsuzaki
Journal:  J Gastroenterol       Date:  2007-09-25       Impact factor: 7.527

8.  Endothelin antagonism in portal hypertensive mice: implications for endothelin receptor-specific signaling in liver disease.

Authors:  Hong-Qiang Feng; Nate D Weymouth; Don C Rockey
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-03-19       Impact factor: 4.052

9.  Atrasentan (ABT-627) enhances perfusion and reduces hypoxia in a human tumor xenograft model.

Authors:  Kwang Mo Yang; James Russell; Mihaela E Lupu; Hyungjoon Cho; Xiao-Feng Li; Jason A Koutcher; C Clifton Ling
Journal:  Cancer Biol Ther       Date:  2009-10-22       Impact factor: 4.742

10.  Effects of endothelin-1 on hepatic stellate cell proliferation, collagen synthesis and secretion, intracellular free calcium concentration.

Authors:  Chuan-Yong Guo; Jian-Ye Wu; Yun-Bin Wu; Min-Zhang Zhong; Han-Ming Lu
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.